▼ PLUNGE

한스바이오메드

-21.2%
042520KRXHealthcare2026-05-07
23,250
종가
29,500
전일 종가
-21.19%
변동률
6.1x
거래량 비율

급락 원인

관련 뉴스가 없습니다.

관련 뉴스

Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus2026-04-06
After scrapping AXN-2510, Instil Bio hunts for new drug deals
Stocktitan2026-03-27
Harvard Bioscience shares are trading higher after the company reported preliminary Q4 results, issued FY26 outlook and outlined its long-term strategic focus areas. - Harvard Bioscience (NASDAQ:HBIO)
Benzinga2026-02-10
Fractyl Health sets March 24 call on 2025 results, business updates
Stocktitan2026-03-17
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan2026-04-06

기술적 분석

시그널
볼린저 하단 돌파과매도MACD 약세SMA20 아래
주요 지표
29.29RSI (14)
31710.00SMA 20
26213.24Bollinger Lower
37206.75Bollinger Upper
31710.00Bollinger Mid
-2835.53MACD
-2496.69MACD Signal
-338.84MACD Hist
종목 상세 보기급등주 목록으로
Hans Biomed Corp. +-21.2% 급등 분석 (2026-05-07) | Alpha Lenz